The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CON · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | CON | PCRX | SGRY | MGNX |
|---|---|---|---|---|
| Moat Score (0–100) | 41 (highest) | 41 (highest) | 41 (highest) | 41 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 52 | 55 | 65 (highest) | 55 |
| Pricing power | — | 95 | 33 | 100 (highest) |
| Returns on capital | 87 (highest) | 4 | 4 | 0 |
| Balance-sheet safety | 7 | 28 | 40 (highest) | 28 |
| Capital allocation | 19 | 25 | 65 (highest) | 24 |
| 105% above value if growth stopped today | 24% above value if growth stopped today (largest discount to value if growth stopped today) | No price data | No price data | |
| Market cap | $4.1B | $1.1B | $2.0B | $234M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |